{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:46:28Z","timestamp":1768412788096,"version":"3.49.0"},"reference-count":35,"publisher":"e-Century Publishing Corporation","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/gmgx5873","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T04:12:41Z","timestamp":1745899961000},"page":"3050-3062","source":"Crossref","is-referenced-by-count":1,"title":["Value of a multi-indicator model combining Elast PQ technology, blood lipids, liver function, and uric acid for early diagnosis of alcoholic fatty liver disease"],"prefix":"10.62347","volume":"17","author":[{"given":"Linlin","family":"Yue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1186\/s12889-023-15749-x","article-title":"Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis","volume":"23","author":"Niu","year":"2023","unstructured":"Niu X, Zhu L, Xu Y, Zhang M, Hao Y, Ma L, Li Y and Xing H. Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis. BMC Public Health 2023; 23: 859.","journal-title":"BMC Public Health"},{"key":"ref1","unstructured":"Osna NA, Donohue TM Jr and Kharbanda KK. Alcoholic liver disease: pathogenesis and current management. Alcohol Res 2017; 38: 147-161."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/j.sult.2024.07.010","article-title":"Advanced magnetic resonance imaging for detection of liver fibrosis and inflammation in autoimmune hepatitis: a state-of-the-art review","volume":"45","author":"NBN","year":"2024","unstructured":"Gomes NBN, Torres US, Ferraz M and D’Ippolito G. Advanced magnetic resonance imaging for detection of liver fibrosis and inflammation in autoimmune hepatitis: a state-of-the-art review. Semin Ultrasound CT MR 2024; 45: 464-475.","journal-title":"Semin Ultrasound CT MR"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"990306","DOI":"10.3389\/fonc.2023.990306","article-title":"Quantitative analysis of artificial intelligence on liver cancer: a bibliometric analysis","volume":"13","author":"Xiong","year":"2023","unstructured":"Xiong M, Xu Y, Zhao Y, He S, Zhu Q, Wu Y, Hu X and Liu L. Quantitative analysis of artificial intelligence on liver cancer: a bibliometric analysis. Front Oncol 2023; 13: 990306.","journal-title":"Front Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.dld.2023.10.020","article-title":"Prospective evaluation of liver shearwave elastography measurements with 3 different technologies and same day liver biopsy in patients with chronic liver disease","volume":"56","author":"Atzori","year":"2024","unstructured":"Atzori SM, Pasha Y, Maurice JB, Taylor-Robinson SD, Campbell L and Lim AKP. Prospective evaluation of liver shearwave elastography measurements with 3 different technologies and same day liver biopsy in patients with chronic liver disease. Dig Liver Dis 2024; 56: 484-494.","journal-title":"Dig Liver Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3390\/diagnostics13040788","article-title":"How to identify advanced fibrosis in adult patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) using ultrasound elastography-a review of the literature and proposed multistep approach","volume":"13","author":"Taru","year":"2023","unstructured":"Taru MG, Neamti L, Taru V, Procopciuc LM, Procopet B and Lupsor-Platon M. How to identify advanced fibrosis in adult patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) using ultrasound elastography-a review of the literature and proposed multistep approach. Diagnostics (Basel) 2023; 13: 788.","journal-title":"Diagnostics (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1111\/liv.15297","article-title":"Comparison of point-shear wave elastography (ElastPQ) and transient elastography (FibroScan) for liver fibrosis staging in patients with non-alcoholic fatty liver disease","volume":"42","author":"Roccarina","year":"2022","unstructured":"Roccarina D, Iogna Prat L, Pallini G, Guerrero Misas M, Buzzetti E, Saffioti F, Aricò FM, Mantovani A, Koutli E, Goyale A, Rosselli M, Luong TV, Pinzani M and Tsochatzis EA. Comparison of point-shear wave elastography (ElastPQ) and transient elastography (FibroScan) for liver fibrosis staging in patients with non-alcoholic fatty liver disease. Liver Int 2022; 42: 2195-2203.","journal-title":"Liver Int"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Wang Z, Liu Y, Zhao X, Liu S, Liu Y and Wang D. Aronia melanocarpa prevents alcohol-induced chronic liver injury via regulation of Nrf2 signaling in C57BL\/6 mice. Oxid Med Cell Longev 2020; 2020: 4054520.","DOI":"10.1155\/2020\/4054520"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"11684","DOI":"10.3748\/wjg.v20.i33.11684","article-title":"Diagnosis of alcoholic liver disease","volume":"20","author":"Torruellas","year":"2014","unstructured":"Torruellas C, French SW and Medici V. Diagnosis of alcoholic liver disease. World J Gastroenterol 2014; 20: 11684-11699.","journal-title":"World J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Wu KT, Kuo PL, Su SB, Chen YY, Yeh ML, Huang CI, Yang JF, Lin CI, Hsieh MH, Hsieh MY, Huang CF, Lin WY, Yu ML, Dai CY and Wang HY. Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol. J Clin Lipidol 2016; 10: 420-425, e1.","DOI":"10.1016\/j.jacl.2015.12.026"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1175985","DOI":"10.3389\/fendo.2023.1175985","article-title":"Study of Xuanhuang Pill in protecting against alcohol liver disease using ultra-performance liquid chromatography\/time-of-flight mass spectrometry and network pharmacology","volume":"14","author":"Cui","year":"2023","unstructured":"Cui X, Du M, Wei K, Dai C, Yang RYH, Zhou B, Luo Z, Yang X, Yu Y, Lin W, Wu Y and Liu Y. Study of Xuanhuang Pill in protecting against alcohol liver disease using ultra-performance liquid chromatography\/time-of-flight mass spectrometry and network pharmacology. Front Endocrinol (Lausanne) 2023; 14: 1175985.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"18211","DOI":"10.1038\/s41598-023-45564-8","article-title":"The effect of lipid metabolism disorder on patients with hyperuricemia using Multi-Omics analysis","volume":"13","author":"Ma","year":"2023","unstructured":"Ma L, Wang J, Ma L, Ge Y and Wang XM. The effect of lipid metabolism disorder on patients with hyperuricemia using Multi-Omics analysis. Sci Rep 2023; 13: 18211.","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4166\/kjg.2020.76.2.60","article-title":"Diagnosis and severity assessment of alcohol-related liver disease","volume":"76","author":"Kim","year":"2020","unstructured":"Kim E and Park SH. Diagnosis and severity assessment of alcohol-related liver disease. Korean J Gastroenterol 2020; 76: 60-64.","journal-title":"Korean J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.3390\/ijms20112712","article-title":"Pathogenesis, early diagnosis, and therapeutic management of alcoholic liver disease","volume":"20","author":"Kong","year":"2019","unstructured":"Kong LZ, Chandimali N, Han YH, Lee DH, Kim JS, Kim SU, Kim TD, Jeong DK, Sun HN, Lee DS and Kwon T. Pathogenesis, early diagnosis, and therapeutic management of alcoholic liver disease. Int J Mol Sci 2019; 20: 2712.","journal-title":"Int J Mol Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","unstructured":"Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, Mathurin P, Mueller S, Szabo G and Tsukamoto H. Alcoholic liver disease. Nat Rev Dis Primers 2018; 4: 16.","journal-title":"Nat Rev Dis Primers"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12882-023-03137-x","article-title":"Sex-specific association of body mass index and fatty liver index with prevalence of renal hyperfiltration: a cross sectional study using Japanese health check-up data","volume":"24","author":"Kitazawa","year":"2023","unstructured":"Kitazawa A and Fukuda Y. Sex-specific association of body mass index and fatty liver index with prevalence of renal hyperfiltration: a cross sectional study using Japanese health check-up data. BMC Nephrol 2023; 24: 85.","journal-title":"BMC Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"6301","DOI":"10.3390\/molecules26206301","article-title":"Monascin and ankaflavin of monascus purpureus prevent alcoholic liver disease through regulating AMPK-mediated lipid metabolism and enhancing both anti-inflammatory and anti-oxidative systems","volume":"26","author":"Lai","year":"2021","unstructured":"Lai JR, Hsu YW, Pan TM and Lee CL. Monascin and ankaflavin of monascus purpureus prevent alcoholic liver disease through regulating AMPK-mediated lipid metabolism and enhancing both anti-inflammatory and anti-oxidative systems. Molecules 2021; 26: 6301.","journal-title":"Molecules"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"719","DOI":"10.14218\/jcth.2021.00173","article-title":"Alcohol and metabolic-associated fatty liver disease","volume":"9","author":"Sun","year":"2021","unstructured":"Sun FR and Wang BY. Alcohol and metabolic-associated fatty liver disease. J Clin Transl Hepatol 2021; 9: 719-730.","journal-title":"J Clin Transl Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"710285","DOI":"10.3389\/fphys.2021.710285","article-title":"Similarities and differences: a comparative review of the molecular mechanisms and effectors of NAFLD and AFLD","volume":"12","author":"Zhang","year":"2021","unstructured":"Zhang P, Wang W, Mao M, Gao R, Shi W, Li D, Calderone R, Sui B, Tian X and Meng X. Similarities and differences: a comparative review of the molecular mechanisms and effectors of NAFLD and AFLD. Front Physiol 2021; 12: 710285.","journal-title":"Front Physiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1002\/jsfa.10915","article-title":") fermentation liquid protects against alcoholic liver disease linked to regulation of liver metabolome and the abundance of gut microbiota","volume":"101","author":"Ran","year":"2021","unstructured":"Ran B, Guo CE, Li W, Li W, Wang Q, Qian J and Li H. Sea buckthorn (Hippophae rhamnoides L.) fermentation liquid protects against alcoholic liver disease linked to regulation of liver metabolome and the abundance of gut microbiota. J Sci Food Agric 2021; 101: 2846-2854.","journal-title":"J Sci Food Agric"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.7754\/Clin.Lab.2013.130228","article-title":"High-density lipoprotein size distribution can differ between subjects with alcoholic and non-alcoholic fatty liver disease","volume":"60","author":"Tsuzaki","year":"2014","unstructured":"Tsuzaki K, Kotani K, Fujiwara S, Sano Y and Sakane N; Mima Study Group. High-density lipoprotein size distribution can differ between subjects with alcoholic and non-alcoholic fatty liver disease. Clin Lab 2014; 60: 319-322.","journal-title":"Clin Lab"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/nu14061127","article-title":"Added fructose in non-alcoholic fatty liver disease and in metabolic syndrome: a narrative review","volume":"14","author":"Coronati","year":"2022","unstructured":"Coronati M, Baratta F, Pastori D, Ferro D, Angelico F and Del Ben M. Added fructose in non-alcoholic fatty liver disease and in metabolic syndrome: a narrative review. Nutrients 2022; 14: 1127.","journal-title":"Nutrients"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/acer.13346","article-title":"Liver injury and endotoxemia in male and female alcohol-dependent individuals admitted to an alcohol treatment program","volume":"41","author":"Kirpich","year":"2017","unstructured":"Kirpich IA, McClain CJ, Vatsalya V, Schwandt M, Phillips M, Falkner KC, Zhang L, Harwell C, George DT and Umhau JC. Liver injury and endotoxemia in male and female alcohol-dependent individuals admitted to an alcohol treatment program. Alcohol Clin Exp Res 2017; 41: 747-757.","journal-title":"Alcohol Clin Exp Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1097\/TA.0000000000002868","article-title":"Impact of uric acid on liver injury and intestinal permeability following resuscitated hemorrhagic shock in rats","volume":"89","author":"Khazoom","year":"2020","unstructured":"Khazoom F, L’Écuyer S, Gilbert K, Gagné MA, Bouchard C, Rose CF, Rousseau G and Charbonney E. Impact of uric acid on liver injury and intestinal permeability following resuscitated hemorrhagic shock in rats. J Trauma Acute Care Surg 2020; 89: 1076-1084.","journal-title":"J Trauma Acute Care Surg"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.2147\/NDT.S409210","article-title":"The role of ElastPQ in assessing liver stiffness for non-alcoholic fatty liver disease in patients treated with atypical antipsychotic drugs","volume":"19","author":"Sun","year":"2023","unstructured":"Sun L, Li N, Zhang L and Chen J. The role of ElastPQ in assessing liver stiffness for non-alcoholic fatty liver disease in patients treated with atypical antipsychotic drugs. Neuropsychiatr Dis Treat 2023; 19: 1491-1502.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"15566","DOI":"10.1038\/s41598-021-94990-z","article-title":"Photocrosslinkable liver extracellular matrix hydrogels for the generation of 3D liver microenvironment models","volume":"11","author":"Ravichandran","year":"2021","unstructured":"Ravichandran A, Murekatete B, Moedder D, Meinert C and Bray LJ. Photocrosslinkable liver extracellular matrix hydrogels for the generation of 3D liver microenvironment models. Sci Rep 2021; 11: 15566.","journal-title":"Sci Rep"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"8859338","DOI":"10.1155\/2021\/8859338","article-title":"Transient elastography in alcoholic liver disease and nonalcoholic fatty liver disease: a systemic review and meta-analysis","volume":"2021","author":"Cai","year":"2021","unstructured":"Cai C, Song X, Chen X, Zhou W, Jin Q, Chen S and Ji F. Transient elastography in alcoholic liver disease and nonalcoholic fatty liver disease: a systemic review and meta-analysis. Can J Gastroenterol Hepatol 2021; 2021: 8859338.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5009\/gnl16477","article-title":"Pathophysiology and management of alcoholic liver disease: update 2016","volume":"11","author":"Stickel","year":"2017","unstructured":"Stickel F, Datz C, Hampe J and Bataller R. Pathophysiology and management of alcoholic liver disease: update 2016. Gut Liver 2017; 11: 173-188.","journal-title":"Gut Liver"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3390\/ijms23020774","article-title":"Crosstalk between oxidative stress and inflammatory liver injury in the pathogenesis of alcoholic liver disease","volume":"23","author":"YM","year":"2022","unstructured":"Yang YM, Cho YE and Hwang S. Crosstalk between oxidative stress and inflammatory liver injury in the pathogenesis of alcoholic liver disease. Int J Mol Sci 2022; 23: 774.","journal-title":"Int J Mol Sci"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"13128","DOI":"10.18632\/aging.103401","article-title":"Long-term low-dose ethanol intake improves healthspan and resists high-fat diet-induced obesity in mice","volume":"12","author":"Diao","year":"2020","unstructured":"Diao Y, Nie J, Tan P, Zhao Y, Zhao T, Tu J, Ji H, Cao Y, Wu Z, Liang H, Huang H, Li Y, Gao X and Zhou L. Long-term low-dose ethanol intake improves healthspan and resists high-fat diet-induced obesity in mice. Aging (Albany NY) 2020; 12: 13128-13146.","journal-title":"Aging (Albany NY)"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12072-020-10027-z","article-title":"Application of point shear wave elastography in alcohol-related liver disease","volume":"14","author":"Wong","year":"2020","unstructured":"Wong VW. Application of point shear wave elastography in alcohol-related liver disease. Hepatol Int 2020; 14: 161-163.","journal-title":"Hepatol Int"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1093\/eurheartj\/ehn334","article-title":"NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus","volume":"29","author":"Huelsmann","year":"2008","unstructured":"Huelsmann M, Neuhold S, Strunk G, Moertl D, Berger R, Prager R, Abrahamian H, Riedl M, Pacher R, Luger A and Clodi M. NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus. Eur Heart J 2008; 29: 2259-2264.","journal-title":"Eur Heart J"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"885624","DOI":"10.3389\/fpubh.2022.885624","article-title":"A visualized dynamic prediction model for overall survival in elderly patients with pancreatic cancer for smart medical services","volume":"10","author":"Zhong","year":"2022","unstructured":"Zhong J, Liao X, Peng S, Cao J, Liu Y, Liu C, Qiu J, Guan X, Zhang Y, Liu X and Peng S. A visualized dynamic prediction model for overall survival in elderly patients with pancreatic cancer for smart medical services. Front Public Health 2022; 10: 885624.","journal-title":"Front Public Health"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.14218\/jcth.2021.00317","article-title":"Development and validation of a nomogram for prediction of the risk of MAFLD in an overweight and obese population","volume":"10","author":"Song","year":"2022","unstructured":"Song D, Ge Q, Chen M, Bai S, Lai X, Huang G, Liu M, Lin M, Xu J and Dong F. Development and validation of a nomogram for prediction of the risk of MAFLD in an overweight and obese population. J Clin Transl Hepatol 2022; 10: 1027-1033.","journal-title":"J Clin Transl Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"4073503","DOI":"10.1155\/2021\/4073503","article-title":"Nomogram to predict the survival of chinese patients with alcohol-related liver disease","volume":"2021","author":"Duan","year":"2021","unstructured":"Duan F, Liu C, Liu Y, Chang C, Zhai H, Xing H, Cheng J and Yang S. Nomogram to predict the survival of chinese patients with alcohol-related liver disease. Can J Gastroenterol Hepatol 2021; 2021: 4073503.","journal-title":"Can J Gastroenterol Hepatol"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/4\/ajtr0164026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:57:27Z","timestamp":1766023047000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/4\/ajtr0164026.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/gmgx5873","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}